Haemonetics Corp. buy BTIG Research
Start price
09.01.26
/
50%
€72.00
Target price
09.01.27
€75.54
Performance (%)
5.56%
Price
10.08.26
€76.00
Summary
This prediction is currently active. With a performance of 5.56%, the BUY prediction by BTIG_Research for Haemonetics Corp. is trending in the right direction. This prediction currently runs until 09.01.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 0.662% | 0.662% |
| iShares Core DAX® | 0.184% | 5.072% |
| iShares Nasdaq 100 | -0.770% | -2.079% |
| iShares Nikkei 225® | 0.733% | -3.346% |
| iShares S&P 500 | -0.166% | 0.904% |
Comments by BTIG_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by BTIG_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€68.00
26.06.26
26.06.26
€73.86
26.06.27
26.06.27
11.76%
10.08.26
10.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€64.00
17.06.26
17.06.26
€72.34
17.06.27
17.06.27
18.75%
10.08.26
10.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€74.64
06.02.27
06.02.27
57.02%
10.08.26
10.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€67.50
21.11.25
21.11.25
€76.29
21.11.26
21.11.26
12.59%
10.08.26
10.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.50
06.11.25
06.11.25
€76.46
06.11.26
06.11.26
32.17%
10.08.26
10.08.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
10.09.24
10.09.24
€101.52
10.09.25
10.09.25
-32.03%
11.09.25
11.09.25